Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020)

Cartesian Therapeutics (RNAC) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$102000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to -$102000.0 in Q4 2020 year-over-year; TTM through Dec 2021 was -$102000.0, a 0.0% change, with the full-year FY2020 number at $24.7 million, changed N/A from a year prior.
  • Long-Term Debt Issuances was -$102000.0 for Q4 2020 at Cartesian Therapeutics.
  • In the past five years, Long-Term Debt Issuances ranged from a high of -$102000.0 in Q4 2020 to a low of -$102000.0 in Q4 2020.